Literature DB >> 15051837

Regression of dietary copper restriction-induced cardiomyopathy by copper repletion in mice.

Laila Elsherif1, Lipeng Wang, Jack T Saari, Y James Kang.   

Abstract

Dietary copper deficiency (CuD)(3) leads to cardiac hypertrophy in various animal models. We showed recently that heart failure develops after hypertrophy in FVB mice fed a CuD diet. The present study was undertaken to determine whether CuD-induced cardiac failure is reversible upon copper repletion (CuR). Dams of FVB mice were fed a CuD diet (0.3 mg/kg) starting from d 3 postdelivery; the weanling pups were fed the same diet until CuR with 6.0 mg/kg Cu in the diet at 4 or 5 wk of age. CuR at 4 wk of age prevented the body weight loss; at 5 wk of age, it resulted in the regaining of the lost weight caused by CuD. A significant regression of CuD-induced cardiac hypertrophy was observed in the CuR mice. Histopathological examination revealed that CuR eliminated CuD-caused lipid deposition in the myocardium, and electron microscopy demonstrated that CuD-induced ultrastructural changes such as mitochondrial swelling and organelle structural disarray were all reversed in the CuR mice. Hemodynamic analysis showed that the CuD-depressed systolic and diastolic parameters such as the maximal rate of left ventricular pressure rise (+dP/dt) and decline (-dP/dt), and the contraction and relaxation times were completely recovered in the CuR mice. Furthermore, the CuD-blunted myocardial responses to the beta-adrenergic agonist, isoproterenol, were also restored in the CuR mice. This study thus demonstrates for the first time that CuR results in the regression of heart failure induced by CuD as demonstrated by the reversal of depressed cardiac hemodynamic and contractile function and the restored responsiveness to beta-adrenergic stimulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15051837     DOI: 10.1093/jn/134.4.855

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  14 in total

Review 1.  Transition metals and mitochondrial metabolism in the heart.

Authors:  Amy K Rines; Hossein Ardehali
Journal:  J Mol Cell Cardiol       Date:  2012-06-02       Impact factor: 5.000

Review 2.  Micronutrients and their supplementation in chronic cardiac failure. An update beyond theoretical perspectives.

Authors:  Klaus K Witte; Andrew L Clark
Journal:  Heart Fail Rev       Date:  2006-03       Impact factor: 4.214

3.  Trientine selectively delivers copper to the heart and suppresses pressure overload-induced cardiac hypertrophy in rats.

Authors:  Jiaming Liu; Chen Chen; Yinjie Liu; Xiaorong Sun; Xueqin Ding; Liying Qiu; Pengfei Han; Y James Kang
Journal:  Exp Biol Med (Maywood)       Date:  2018-11-24

Review 4.  Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease.

Authors:  Garth J S Cooper
Journal:  Drugs       Date:  2011-07-09       Impact factor: 9.546

Review 5.  Regression of pathological cardiac hypertrophy: signaling pathways and therapeutic targets.

Authors:  Jianglong Hou; Y James Kang
Journal:  Pharmacol Ther       Date:  2012-06-29       Impact factor: 12.310

6.  A copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: a randomised placebo-controlled study.

Authors:  G J S Cooper; A A Young; G D Gamble; C J Occleshaw; A M Dissanayake; B R Cowan; D H Brunton; J R Baker; A R J Phillips; C M Frampton; S D Poppitt; R N Doughty
Journal:  Diabetologia       Date:  2009-01-27       Impact factor: 10.122

7.  The loss of copper is associated with the increase in copper metabolism MURR domain 1 in ischemic hearts of mice.

Authors:  Kui Li; Chen Li; Ying Xiao; Tao Wang; Y James Kang
Journal:  Exp Biol Med (Maywood)       Date:  2018-05

8.  Changes in copper and zinc status and response to dietary copper deficiency in metallothionein-overexpressing transgenic mouse heart.

Authors:  Y James Kang; Youchun Jiang; Jack T Saari
Journal:  J Nutr Biochem       Date:  2007-08-17       Impact factor: 6.048

9.  Regression of copper-deficient heart hypertrophy: reduction in the size of hypertrophic cardiomyocytes.

Authors:  Zhanxiang Zhou; W Thomas Johnson; Y James Kang
Journal:  J Nutr Biochem       Date:  2008-11-22       Impact factor: 6.048

10.  COMMD1 upregulation is involved in copper efflux from ischemic hearts.

Authors:  Chen Li; Tao Wang; Ying Xiao; Kui Li; Xia Meng; Y James Kang
Journal:  Exp Biol Med (Maywood)       Date:  2020-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.